Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SKB reports new delta-receptor agonists/antagonists

Jan. 16, 1997

New antimigraine agent from Pfizer

Jan. 15, 1997

Japanese scientists report cholecystokinin antagonists

Jan. 15, 1997

Second IND submitted for new ADHD therapy

Jan. 14, 1997

Subcutaneous BDNF not effective in ALS

Jan. 14, 1997

Neurogen reports CRF ligands for stress-related disorders

Jan. 14, 1997

Connective Therapeutics commences phase I/II of TCR vaccine for multiple sclerosis

Jan. 13, 1997

MRC scientists investigate role of somatostatin receptors in the CNS

Jan. 13, 1997

French researcher discloses preventive effects of tryptamine derivatives

Jan. 13, 1997

Titan in-licenses antipsychotic drug from HMR

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...